Alison Bauerlein - 03 Dec 2021 Form 4 Insider Report for Pear Therapeutics, Inc.

Role
Director
Signature
/s/ Stacie S. Aarestad, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
03 Dec 2021
Net transactions value
$0
Form type
4
Filing time
07 Dec 2021, 16:27:14 UTC
Previous filing
03 Dec 2021
Next filing
10 Dec 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PEARQ Stock Option (Right to Buy) Award $0 +70,560 $0.000000 70,560 03 Dec 2021 Class A Common Stock 70,560 $9.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option becomes exercisable for 33% shares on December 3, 2022, 33% of the shares on December 3, 2023 and 34% of the shares on December 3, 2024.